TELA Bio 

$1.0100
15
-$0.08-7.76% 20:00 Today
+$0.00+0%21:05After hours

Statistics

Day High
1.12
Day Low
0.98
52W High
1.56
52W Low
0.501
Volume
267,753
Avg. Volume
215,445
Mkt Cap
45.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 11Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.25
-0.22
-0.19
-0.16
Expected EPS
-0.155633
Actual EPS
N/A

Financials

-48.37%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
80.28MRevenue
-38.83MNet Income

Analyst Ratings

$2.00Average Price Target
The highest estimate is ⁦2.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TELA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson operates in the medical devices segment, offering products that could compete with TELA Bio's soft tissue reinforcement solutions.
Medtronic
MDT
Mkt Cap110.49B
Medtronic offers a wide range of medical devices that can compete with TELA Bio's offerings, especially in the surgical and wound care markets.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation provides medical solutions that could directly compete with TELA Bio's hernia repair and reconstructive surgery products.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation's medical and surgical equipment, including surgical meshes, can compete with TELA Bio's portfolio.
Baxter International
BAX
Mkt Cap12.14B
Baxter International Inc. offers advanced surgical products, including biologics and biosurgery products, that compete with TELA Bio's solutions.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories, with its range of medical devices and health care products, competes in the same space as TELA Bio, particularly in surgical care.
Intuitive Surgical
ISRG
Mkt Cap138.47B
Intuitive Surgical, known for its robotic-assisted surgical systems, competes indirectly by offering advanced surgical options that could reduce the need for traditional surgical meshes.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be used in procedures similar to those targeted by TELA Bio.
Integra Lifesciences
IART
Mkt Cap986.16M
Integra LifeSciences, a provider of regenerative technologies, directly competes with TELA Bio in the market for surgical reconstruction and repair products.

About

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Show More
CEO
Heather Getz
Employees
218
Country
United States
ISIN
US8723811084

Listings

0 Comments

Share your thoughts

FAQs

What is TELA Bio stock price today?▼
The current price of TELA is $1.01 USD — it has decreased by -7.76% in the past 24 hours. Watch TELA Bio stock price performance more closely on the chart.
What is TELA Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange TELA Bio stocks are traded under the ticker TELA.
Is TELA Bio stock price growing?▼
TELA stock has fallen by -3.81% compared to the previous week, the month change is a -7.34% fall, over the last year TELA Bio has showed a -31.76% decrease.
What is TELA Bio market cap?▼
Today TELA Bio has the market capitalization of 45.59M
When is the next TELA Bio earnings date?▼
TELA Bio is going to release the next earnings report on November 11, 2026.
What were TELA Bio earnings last quarter?▼
TELA earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.17 USD resulting in a -15.1% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TELA Bio revenue for the last year?▼
TELA Bio revenue for the last year amounts to 80.28M USD.
What is TELA Bio net income for the last year?▼
TELA net income for the last year is -38.83M USD.
How many employees does TELA Bio have?▼
As of October 15, 2026, the company has 218 employees.
In which sector is TELA Bio located?▼
TELA Bio operates in the Health & Wellness sector.
When did TELA Bio complete a stock split?▼
The last stock split for TELA Bio was on October 15, 2007 with a ratio of 1:250.
Where is TELA Bio headquartered?▼
TELA Bio is headquartered in MALVERN, United States.